• Login
    View Item 
    •   Home
    • Research, Student
    • Theses and Dissertations
    • View Item
    •   Home
    • Research, Student
    • Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MercerCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    About URSA

    Collecting PolicyLicense AgreementDigitization SpecificationsRemoval PolicyHarmful Language Statement

    Statistics

    Display statistics

    Novel Akt Pathway Inhibitors: An Integrated Approach Between Theory And Experiment

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Uko_mercer_1160E_10179.pdf
    Size:
    3.487Mb
    Format:
    PDF
    Download
    Average rating
     
       votes
    Cast your vote
    You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.
    Star rating
     
    Your vote was cast
    Thank you for your feedback
    Author
    Uko, Nne
    Keyword
    Mercer University -- Dissertations
    College of Pharmacy
    
    Metadata
    Show full item record
    URI
    http://hdl.handle.net/10898/10081
    Title
    Novel Akt Pathway Inhibitors: An Integrated Approach Between Theory And Experiment
    Abstract
    The AKT kinase signaling pathway regulates growth and survival of cells, and it is linked to the progression of numerous types of human cancers. Several studies have shown that deactivation of Akt can promote inhibition of cancer cell growth. The objective of this study was to investigate the efficacy of novel AKT pathway inhibitors in terms of their ability to deactivate AKT and inhibit human tumor cell growth. These compounds were identified using computer-assisted drug design (CADD) methods. Pharmacophore modeling was used to screen hundreds of small molecule compounds as potential AKT pathway inhibitors. Five commercially available putative AKT pathway inhibitors were identified that had the necessary pharmacophoric features. Three compounds, labeled B, C and D were modeled after solenopsin, an alkaloid from the venom of fire ants and the remaining two, compound A and E were designed after a known Akt inhibitor. Cultured tumorigenic ras-transformed cells (WBras1) and human lung carcinoma cells (H2009) were treated with one of the test compounds at varying non-cytotoxic concentrations, or with the vehicle (DMSO). Akt phosphorylation levels at the Ser473 and Thr308 site were monitored. Among all the cells treated, compound B significantly decreased. phosphorylation at varying time points in both tumorigenic cell types at low micromolar concentrations. Downstream Akt effectors were assessed for alternations in pathway regulatory activity. The results indicated that compounds B and C effectively downregulated Akt pathway activation through reduced phosphorylation of Akt and downstream effectors in the Akt pathway. To determine whether any of the CADD compounds directly inhibit Akt, an in-vitro Akt kinase kit assay was utilized. The study revealed that none of the CADD compounds inhibited Akt phosphorylation at the ATP activation site. In this dissertation, it has been revealed that only compounds B and C decreased cancer cell growth in human lung carcinoma cells. The outcome of this investigation confirmed that by inhibiting activation of Akt, inhibition of cancer cell growth can be achieved. Compound B was the most effective of the 5 compounds in inhibiting AKT phosphorylation. Compound B was also the most effective in inhibiting H2009 cell growth. In addition, we studied and showed that an extract of an anticancer herbal mix (labeled as BAH), comprised of plantain (Musca paradisiaca), yam (Dioscorea rotundata) and fish (Atlantic herring), significantly decreased Akt phosphorylation, blocked cancer cell growth and inhibited the activity of Akt in the presence of ATP. Taken together, this study highlights the utility of CADD in identifying promising anti-cancer agents and for the first time unveils novel solenopsin derivatives that hamper the activation of Akt, including alteration of Akt signaling in the pathway. The inhibitory effect in vitro of a proprietary anticancer herbal extract for the first time in human lung cancer cells is also demonstrated.
    Collections
    Theses and Dissertations

    entitlement

     

    DSpace software (copyright © 2002 - 2022)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.